Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Winstanley

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)Freddy Frost, Gregory R Young, Laura Wright, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 26, 2015
Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis PatientsJaspreet Singh Sahota, Claire Mary Smith, Priya Radhakrishnan, et al.
Journal of Medical Microbiology|September 26, 2019
Genomic and phenotypic comparison of environmental and patient-derived isolates of <i>Pseudomonas aeruginosa</i> suggest that antimicrobial resistance is rare within the environmentKay A Ramsay, Samuel J T Wardell, Wayne M Patrick, et al.
The European Respiratory Journal|November 2, 2013
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasisAnthony De Soyza, Audrey Perry, Amanda J Hall, et al.
The Journal of Infectious Diseases|August 14, 2015
Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung InfectionsAndrée-Ann Lemieux, Julie Jeukens, Irena Kukavica-Ibrulj, et al.
Plos One|December 1, 2017
Campylobacter jejuni transcriptome changes during loss of culturability in waterChristina Bronowski, Kasem Mustafa, Ian Goodhead, et al.
Journal of Bacteriology|July 5, 2005
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistancePrabhakar Salunkhe, Catherine H M Smart, J Alun W Morgan, et al.
Microbiology (Reading, England)|January 30, 2008
A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coliChristina Bronowski, Shirley L Smith, Kyoko Yokota, et al.
The Biochemical Journal|April 13, 2023
Correction: Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
The Biochemical Journal|December 12, 2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)Freddy Frost, Gregory R Young, Laura Wright, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 26, 2015
Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis PatientsJaspreet Singh Sahota, Claire Mary Smith, Priya Radhakrishnan, et al.
Journal of Medical Microbiology|September 26, 2019
Genomic and phenotypic comparison of environmental and patient-derived isolates of <i>Pseudomonas aeruginosa</i> suggest that antimicrobial resistance is rare within the environmentKay A Ramsay, Samuel J T Wardell, Wayne M Patrick, et al.
The European Respiratory Journal|November 2, 2013
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasisAnthony De Soyza, Audrey Perry, Amanda J Hall, et al.
The Journal of Infectious Diseases|August 14, 2015
Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung InfectionsAndrée-Ann Lemieux, Julie Jeukens, Irena Kukavica-Ibrulj, et al.
Plos One|December 1, 2017
Campylobacter jejuni transcriptome changes during loss of culturability in waterChristina Bronowski, Kasem Mustafa, Ian Goodhead, et al.
Journal of Bacteriology|July 5, 2005
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistancePrabhakar Salunkhe, Catherine H M Smart, J Alun W Morgan, et al.
Microbiology (Reading, England)|January 30, 2008
A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coliChristina Bronowski, Shirley L Smith, Kyoko Yokota, et al.
The Biochemical Journal|April 13, 2023
Correction: Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
The Biochemical Journal|December 12, 2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
Pageof 12